Approval · Notice of Compliance 7334 · 2005
RAPAMUNE: Notice of Compliance 7334
Issued August 29, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7334
- Date
- August 29, 2005
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 2 mg tablets
- Therapeutic class
- Immunosuppressive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAPAMUNE | 02270617 | Cancelled Pre Market |
Medicinal ingredients
- SIROLIMUS 2 MG per TAB